UnitedHealth Group released its first-quarter 2026 financial results on April 21, 2026, reporting consolidated revenues of $111.7 billion. This figure represents a 2% increase compared to the $109.6 billion recorded in the same period last year. The company’s earnings from operations reached $9.0 billion, while net income for the quarter was $6.28 billion, or $6.90 per share. Adjusted net earnings for the first quarter were $7.23 per share.
Based on its first-quarter performance, UnitedHealth Group raised its full-year 2026 outlook. The company now expects adjusted net earnings to exceed $18.25 per share, up from previous projections. GAAP net earnings for the full year are anticipated to be greater than $17.35 per share. Chief Executive Officer Stephen Hemsley stated that the results reflect actions taken over the last several quarters to modernize health care delivery and improve connectivity for providers and consumers.
The company’s medical care ratio, a key metric representing the percentage of premiums spent on medical claims, improved to 83.9% in the first quarter of 2026. This is a 90-basis-point decrease from the 84.8% reported in the first quarter of 2025. Management attributed the improvement to disciplined pricing and effective medical cost management, which helped offset consistently elevated utilization and unit cost trends. The operating cost ratio rose to 13.8%, compared to 12.4% a year earlier, reflecting increased investments in technology, cybersecurity, and personnel.
Performance across the company’s primary business segments was mixed. UnitedHealthcare, the insurance division, reported revenues of $86.3 billion, a 2% year-over-year increase. The segment’s operating margin expanded to 6.6%, up from 6.2% in the prior year, driven by repricing efforts across its various lines of business. As of March 31, 2026, UnitedHealthcare served 49.1 million domestic consumers, a decrease from the 49.8 million served at the end of 2025.
The Optum health services segment reported total revenues of $63.7 billion, a slight decrease of 0.3% from the first quarter of 2025. Within this segment, Optum Health revenues fell 3% to $24.1 billion, primarily due to a decline in value-based care membership and elevated medical costs. However, Optum Rx saw revenues grow 2% to $35.7 billion, supported by expansion in specialty pharmacy services. Optum Insight reported revenue of $5.1 billion, compared to $5.0 billion in the year-ago period.
UnitedHealth Group also highlighted several strategic developments, including a planned $1.5 billion investment in artificial intelligence to modernize health care delivery and administrative processes. During the quarter, the company entered into an agreement to acquire Alegeus Technologies, a platform for health care benefits administration. Financially, the company generated $8.9 billion in cash flows from operations during the first quarter. Its debt-to-total-capital ratio stood at 42.9% as of March 31, 2026, and the company expects to deploy at least $2 billion for share repurchases by the end of the second quarter.